⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.

SBILIFE - Investment Analysis: Buy Signal or Bull Trap?

← Back to List

⭐ Rating: 2.5

Last Updated Time : 19 Sept 26, 01:47 am

Key Parameters

⭐ Investment Rating: 2.5

ROE13.7 %
ROCE15.0 %
PEG Ratio5.23
Dividend Yield0.16 %
Debt to equity0.00
PAT Qtr725 Cr.
PAT Prev Qtr805 Cr.
Qtr Profit Var22.0 %
Show all parameters (20 more)
Stock CodeSBILIFE
Market Cap1,74,138 Cr.
Current Price1,731 ₹
High / Low2,133 ₹
Stock P/E67.0
Book Value201 ₹
Face Value10.0 ₹
DMA 501,774 ₹
DMA 2001,835 ₹
Chg in FII Hold-0.56 %
Chg in DII Hold0.54 %
RSI47.5
MACD-24.5
Volume9,42,180
Avg Vol 1Wk12,30,131
Low price1,653 ₹
High price2,133 ₹
52w Index16.3 %
EPS25.9 ₹
Industry PE63.8

🏭 Industry

The life insurance industry in India remains robust, driven by rising disposable incomes and increasing awareness of financial planning products. While competitive pressures exist due to regulatory changes and intensified competition among insurers, the long-term growth potential for this sector is underpinned by demographic trends favoring insurance penetration.

✅ Positive

SBILife demonstrates a strong and consistent profit trajectory with PAT growth of 22% quarter-over-quarter, reaching 725 Cr. The company's debt is negligible, providing financial flexibility and reducing risk associated with interest rate fluctuations or economic downturns. Furthermore, the dividend yield offers a modest return that can contribute to compounding returns over time.

⚠️ Limitation

Despite solid profitability, the high P/E ratio of 67.0 relative to the industry average of 63.8 suggests a potentially elevated valuation, particularly considering the company’s ROE of only 13.7%. The ESOP allotment, while not inherently negative, introduces complexity and potential dilution risks that require monitoring.

📉 Company Negative News

Recent news indicates an ESOP allotment of 55,501 shares issued in September 2026 by SBI Life Insurance. Additionally, other life insurance companies’ stocks rose up to 7% on hope of lower commission payment, which could signal increased competition and potentially pressure on margins within the sector – this is a broad industry trend and not specific to SBILife.

🧾 Long-Term Outlook

An entry price zone between 1,680 ₹ and 1,720 ₹ represents a reasonable starting point based on current valuation metrics relative to industry peers. A holding period of 5-10 years would align with the long-term nature of life insurance businesses; monitoring ROE and maintaining a disciplined approach regarding dilution from future share issuances is crucial. Overall, SBILife's consistent profitability and low debt profile justify a cautious yet optimistic outlook for long-term investors.

Choose Technical Analysis or Fundamental Analysis above to load it.

How SBILIFE Rates Across All Strategies

★ 3.5
Entry Price: 1731 ₹.
★ 2.3
Buy Price: 1735 ₹.
Investment
★ 2.5
You're viewing this analysis below.
★ 2.3
Given the current valuation of 65x P/E compared to an industry averag…

NIFTY 50 · Investment

NEXT 50 · Investment

MIDCAP · Investment

SMALLCAP · Investment